191 related articles for article (PubMed ID: 20023890)
1. Dalton Transactions themed issue on metal anticancer compounds.
Sadler PJ
Dalton Trans; 2009 Dec; (48):10647. PubMed ID: 20023890
[No Abstract] [Full Text] [Related]
2. The mechanism of action of platinum anticancer agents--what do we really know about it?
Gibson D
Dalton Trans; 2009 Dec; (48):10681-9. PubMed ID: 20023895
[TBL] [Abstract][Full Text] [Related]
3. Chemistry and biological activity of platinum amidine complexes.
Michelin RA; Sgarbossa P; Sbovata SM; Gandin V; Marzano C; Bertani R
ChemMedChem; 2011 Jul; 6(7):1172-83. PubMed ID: 21630470
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic studies on the reactions of platinum(II) complexes with nitrogen- and sulfur-donor biomolecules.
Bugarčić ŽD; Bogojeski J; Petrović B; Hochreuther S; van Eldik R
Dalton Trans; 2012 Oct; 41(40):12329-45. PubMed ID: 22890549
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, in vitro antitumoral investigations and interaction with plasmid pBR322 DNA of R2eddp-platinum(IV) complexes (R = Et, n-Pr).
Kaluderović GN; Kommera H; Schwieger S; Paethanom A; Kunze M; Schmidt H; Paschke R; Steinborn D
Dalton Trans; 2009 Dec; (48):10720-6. PubMed ID: 20023900
[TBL] [Abstract][Full Text] [Related]
6. On the many roles of NH3 ligands in mono- and multinuclear complexes of platinum.
Sanz Miguel PJ; Roitzsch M; Yin L; Lax PM; Holland L; Krizanovic O; Lutterbeck M; Schürmann M; Fusch EC; Lippert B
Dalton Trans; 2009 Dec; (48):10774-86. PubMed ID: 20023907
[TBL] [Abstract][Full Text] [Related]
7. Copper, gold and silver compounds as potential new anti-tumor metallodrugs.
Tan SJ; Yan YK; Lee PP; Lim KH
Future Med Chem; 2010 Oct; 2(10):1591-608. PubMed ID: 21426151
[TBL] [Abstract][Full Text] [Related]
8. Advances in metal-carbene complexes as potent anti-cancer agents.
Gautier A; Cisnetti F
Metallomics; 2012 Jan; 4(1):23-32. PubMed ID: 22027962
[TBL] [Abstract][Full Text] [Related]
9. Metal/N-heterocyclic carbene complexes: opportunities for the development of anticancer metallodrugs.
Cisnetti F; Gautier A
Angew Chem Int Ed Engl; 2013 Nov; 52(46):11976-8. PubMed ID: 24115500
[No Abstract] [Full Text] [Related]
10. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
Lazarević T; Rilak A; Bugarčić ŽD
Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
[TBL] [Abstract][Full Text] [Related]
11. The Midas touch in cancer chemotherapy: from platinum- to gold-dithiocarbamato complexes.
Ronconi L; Fregona D
Dalton Trans; 2009 Dec; (48):10670-80. PubMed ID: 20023894
[TBL] [Abstract][Full Text] [Related]
12. Recent researches in metal supramolecular complexes as anticancer agents.
Zhou CH; Zhang YY; Yan CY; Wan K; Gan LL; Shi Y
Anticancer Agents Med Chem; 2010 Jun; 10(5):371-95. PubMed ID: 20380632
[TBL] [Abstract][Full Text] [Related]
13. Metals and metal derivatives in medicine.
Colotti G; Ilari A; Boffi A; Morea V
Mini Rev Med Chem; 2013 Feb; 13(2):211-21. PubMed ID: 23438056
[TBL] [Abstract][Full Text] [Related]
14. What do we know about the reduction of Pt(IV) pro-drugs?
Wexselblatt E; Gibson D
J Inorg Biochem; 2012 Dec; 117():220-9. PubMed ID: 22877926
[TBL] [Abstract][Full Text] [Related]
15. Bioactive luminescent transition-metal complexes for biomedical applications.
Ma DL; He HZ; Leung KH; Chan DS; Leung CH
Angew Chem Int Ed Engl; 2013 Jul; 52(30):7666-82. PubMed ID: 23765907
[TBL] [Abstract][Full Text] [Related]
16. Novel metals and metal complexes as platforms for cancer therapy.
Frezza M; Hindo S; Chen D; Davenport A; Schmitt S; Tomco D; Dou QP
Curr Pharm Des; 2010 Jun; 16(16):1813-25. PubMed ID: 20337575
[TBL] [Abstract][Full Text] [Related]
17. Specific interactions of Bi(III) with the Cys-Xaa-Cys unit of a peptide sequence.
Rowinska-Zyrek M; Valensin D; Szyrwiel L; Grzonka Z; Kozlowski H
Dalton Trans; 2009 Nov; (42):9131-40. PubMed ID: 20449188
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands.
Porchia M; Benetollo F; Refosco F; Tisato F; Marzano C; Gandin V
J Inorg Biochem; 2009 Dec; 103(12):1644-51. PubMed ID: 19822369
[TBL] [Abstract][Full Text] [Related]
19. Understanding trans platinum complexes as potential antitumor drugs beyond targeting DNA.
Quiroga AG
J Inorg Biochem; 2012 Sep; 114():106-12. PubMed ID: 22819649
[TBL] [Abstract][Full Text] [Related]
20. Selective aggregation of a platinum-gadolinium complex within a tumor-cell nucleus.
Crossley EL; Aitken JB; Vogt S; Harris HH; Rendina LM
Angew Chem Int Ed Engl; 2010 Feb; 49(7):1231-3. PubMed ID: 20077549
[No Abstract] [Full Text] [Related]
[Next] [New Search]